Evotec SE (XBUL:EVT)
лв 8.815 0 (0%) Market Cap: 2.98 Bil Enterprise Value: 3.16 Bil PE Ratio: 0 PB Ratio: 1.56 GF Score: 66/100

Evotec SE to Provide Information Regarding the Acquisition of Just Biotherapeutics Conference Call Transcript

May 21, 2019 / 11:30AM GMT
Operator

Dear ladies and gentlemen, welcome to the analyst conference call of Evotec SE. At our customer's request, this conference will be recorded. (Operator Instructions) I now hand you over to Dr. Werner Lanthaler, who will start the meeting today. Please go ahead, sir.

Werner Lanthaler
Evotec SE - CEO & Member of Management Board

Good afternoon. This is Werner speaking from Evotec. I'm here with my colleagues, Craig Johnstone, Enno Spillner and Cord Dohrmann. And actually this time, we're in 3 different sites, so I hope that the logistics will work for this conference call. Thank you so much for dialing in. We have uploaded a presentation for this call to the Internet, and we will go alongside this presentation to guide you through the strategic step that we have made in the last 24 hours and announced in the last 24 hours.

We have always been clear in our vision when we enter into the field of biotherapeutics we will only go with a company and a group of people who are the best, share our values and share our vision and where we can share their

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot